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ABSTRACT 
 
 
 
Evaluation of Alterations in Gene Expression in MCF-7 Cells Induced by the 
Agricultural Chemicals Enable and Diazinon. (May 2004)  
Tanmayi Pradeep Mankame, B.Sc., St. Xavier’s College; 
M.Sc., University of Mumbai 
Chair of Advisory Committee: Dr. David. L. Busbee 
Steroid hormones, such as estrogen, are produced in one tissue and carried through 
the blood stream to target tissues in which they bind to highly specific nuclear receptors 
and trigger changes in gene expression and metabolism. Industrial chemicals, such as 
bisphenol A and many agricultural chemicals, including permethrin and fervalerate, are 
known to have estrogenic potential and therefore are estrogen mimics. Widely used 
agricultural chemicals, Enable (fungicide) and Diazinon (insecticide), were evaluated to 
examine their toxicity and estrogenicity. MCF-7 cells, an estrogen-dependent human 
breast cancer line, were utilized for this purpose. MCF-7 cells were treated with 0.033-
3.3 ppb (ng/ml) of Enable and 0.3-67 ppm of Diazinon and gene expression was 
compared to that in untreated cells. Microarray analysis showed down-regulation of 
eight genes and up-regulation of thirty four genes in cells treated with 3.3 ppb of Enable, 
compared to untreated cells. Similarly, in cells treated with 67 ppm of Diazinon, there 
were three genes down-regulated and twenty seven genes up-regulated. For both 
chemicals, specific genes were selected for special consideration. RT-PCR confirmed 
results obtained from analysis of the microarray. These studies were designed to provide 
base-line data on gene expression-altering capacity of specific chemicals and will allow 
assessment of the deleterious effects caused by exposure to the aforementioned 
chemicals. 
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°INTRODUCTION 
 Ligands are molecules that are bound by a protein. Certain ligands, such as the 
steroid hormones, are produced in one tissue and carried through the blood stream to 
target tissues, in which they bind to highly specific nuclear receptor proteins and trigger 
changes in gene expression and metabolism (1). Estrogen, a key steroid hormone, plays 
a vital role in the development and function of the mammary glands, and is active in 
neoplasia of this tissue. In both normal and cancer cells, estrogen receptor alpha (ERα), a 
nuclear receptor, is the primary target of estrogen. ERα is a transcription factor and its 
over-expression may lead to breast cancer. 
 Diethylstilbestrol (DES), a synthetic agonist of 17β-estradiol (E2) which was initially 
prescribed for pregnant women to lower the risk of spontaneous abortion, is now known 
to be associated with an increased risk of breast cancer and clear cell adenocarcinoma 
(CCA) of the vagina and cervix (2). Similarly, alkyl phenols, such as 4-nonyl phenol and 
4-nonyl phenoxycarboxylic acid, appear to have intrinsic estrogenic activity because 
they compete for binding to the E2 receptor (3). Industrial chemicals, such as bisphenol 
A (bisA) and dibutyl phthalate (DBP), are known to exhibit estrogen-like activity and to 
enhance the proliferation of estrogen-responsive breast cancer cell lines (4). When the 
estrogenic potentials of several agricultural chemicals, such as permethrin and 
fervalerate, were examined they were found to be agonists of estrogen, competitively 
inhibiting the binding of estradiol to the estrogen receptor (ER) (5). All of these 
chemicals mimic estrogen. 
 In addition, a variety of chemicals that may alter, or in other ways dysregulate, 
essential gene expression in both developing embryos and adults may be correlated with 
altered morphological, neurological, or immunological development of the fetus.  
Chemically-altered gene expression in pre- and post-natal, developing, and adult humans 
may be correlated with specific physiological functions essential to good health. 
                                                 
This thesis follows the style and format of Endocrinology. 
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   Among the widely used agricultural chemicals Enable (α-[2-(4-chlorophenyl)ethyl]-
α-phenyl-1H-1,2,4-triazole-1-propanenitrile), marketed by Rohm Haas, and Diazinon 
(O,O-diethylO-2-isopropyl-6-methylpyrimidin-4-pyrimidinyl phos-phorothioate), 
distributed by Voluntary Purchasing Groups, Inc., are very interesting due to their 
toxicity in human cells (3,4,36,67). MCF-7 cells, an estrogen dependent human breast 
cancer line (Fig. 1), was used to examine the toxicity and estrogenicity of these 
chemicals. 
  With sequencing of the human genome as well as the advent of microarray 
technology, it is now possible to evaluate which genes have altered expression after 
chemical exposure, which may allow extrapolation to physiological changes at the 
organism level.  
 
 
A B
C
FIG.1. MCF-7 cells at different magnifications. A, B and C at 10, 20 and 40X respectively
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FUNGICIDES 
       The action of most fungicides takes place outside the host and is called “protection”. 
A fungicide that acts outside the host is called a “protectant fungicide”. Most older 
fungicides sprayed on leaves and fruit are of this type. "Therapy" is chemical action 
inside the host. Fungicides may act to produce a toxic reaction in the fungus in several 
different ways. (l) Some may inhibit (slow down or stop) cell wall formation. 
Propiconazole and triadimefon act this way on cereal rusts. (2) The permeability of the 
cell wall may be affected, causing a leaking of nutrient materials from the cell. (3) Some 
fungicides may combine with essential metals to make them unavailable for normal cell 
functions, including the activities of essential enzymes. (4) Other fungicides may inhibit 
respiration, or nuclear division, or may break dormancy of spores (6). 
 Fungicides can be classified as those with a single mode of biochemical action (site 
specific) or those that affect a host of different processes (multi-site).  The main groups 
of fungicides in use at present are listed below in order of their development (6). 
Dithiocarbamates have a broad spectrum of activity against downy mildews, leaf spots 
and rusts. They are non-systemic protectants that are usually used in formulated mixtures 
with other types of fungicides, to help minimize the risk of resistance problems 
occurring (6). Methyl benzimidazole carbamates (MBC)s inhibit cell division and fungal 
growth. These fungicides control many leaf spotting fungi and were at one time 
important in the control of Botrytis grey mould of fruit crops and ornamentals (6). 
Ergosterol biosynthesis inhibitors (EBIs) inhibit synthesis of sterols, which are essential 
for fungal growth. These fungicides can affect a wide range of types of pathogen, 
particularly those causing powdery mildews, rusts and leaf spots. They are used to 
control crop diseases in arable and horticultural production. There are a number of sub-
groups within the compounds that inhibit ergosterol synthesis  the most important of 
which are the triazoles (6). 
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 Phenylamides inhibit RNA synthesis. These are important in the control of downy 
mildews and diseases caused by Phytophthora species (e.g. potato blight) and Pythium. 
These types of fungi cause many important root rot diseases in horticultural crops (6). 
Strobilurins inhibit mitochondrial respiration in fungi, and have activity against all the 
major types of fungi. This is the newest group of fungicides to be marketed and they are 
mainly used in cereal crops, but have some horticultural uses, e.g. apple scab control (6). 
 
Uses 
 According to the U.S. Environmental Protection Agency (EPA), in 1997 
approximately 244,000 and 37,000 tons of fungicides were sold worldwide and in the 
United States, respectively. Triazoles with non-fungicidal applications include, 
azocyclotin is used as an acaricide, paclobutrazole as a growth regulator, carfentrazone 
as an herbicide, and isazophos as an insecticide (7).  
  Azoles play a pivotal role in the treatment of systemic and dermal mycoses. They 
show significantly fewer side effects compared with other antimycotics such as 
amphotericin B. Another significant application of azoles is in the management of 
advanced estrogen responsive breast tumors in post-menopausal women. In these women 
estrogen levels decrease dramatically due to the lack of synthesis in the ovaries (7).  
 
Occurrence in the Environment 
 Enable is a fungicide intended for use as an agricultural and horticultural fungicidal 
spray for the control of leaf spot, yellow and brown rust, powdery mildew and net blotch 
on wheat and barley and apple scab, pear scab and apple powdery mildew on apples and 
pears (8). Enable is moderately persistent to persistent and slightly mobile to immobile 
in soil. Because of its adsorption to soil, the potential for Enable to leach to ground water 
appears to be decreased. However, the potential to contaminate ground water may be 
greater at vulnerable sites (i.e., where soils are low in organic matter and where ground 
water is relatively close to the surface) (9). 
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Chemical and Physical Properties 
 The IUPAC name is (RS)-4-(4-chlorophenyl)-2-phenyl-2-(1H-1,2,4-triazol-1-
ylmethyl)butyronitrile (10). The chemical formula is written as C19H17ClN4. The 
structure is shown in figure 2. 
 
 
 
 
  
 
  
 
 
 Azole fungicides have broad antifungal activity and are used either to prevent fungal 
infections or to cure an infection. Therefore, they are important tools in integrated 
agricultural production. According to their chemical structure, azole compounds are 
classified into triazoles and imidazoles; however, their antifungal activity is due to the 
same molecular mechanism (7). Enable is an azole fungicide which belongs to the 
triazole group (Fig. 2).  Its active ingredient is fenbuconazole. Enable is a white liquid 
that is soluble in water. 
 
 
 
 
 
 
 
 
FIG. 2. Structure of the fungicide Enable (10)
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Acute Exposure Effects 
 Enable is a suspected carcinogen and an endocrine toxicant. It shows low acute 
toxicity when administered orally (LD50 > 2000 mg/kg bw), dermally (LD50 > 5000 
mg/kg bw), or by inhalation (LC50 > 2.1 mg/liter air). It is not irritating to the skin or 
eyes and is not a sensitizer in a Buehler test, but is a weak sensitizer in a maximization 
test. WHO has not yet classified fenbuconazole for acute toxicity (8,9). 
 
Chronic Exposure Effects 
 Carcinogenicity: 78 week studies in mice indicated evidence of carcinogenicity 
based on the occurrence of an increased trend for malignant liver tumors in males and an 
increase in benign and malignant liver tumors in females. Fenbuconazole has been 
classified as a Group C Carcinogen (8, 9)  
 Developmental toxicant: In rats, due to decreased maternal body weight compared to 
controls and increase in early and late resorption with a decrease in number of live 
fetuses per dam (8, 9). 
 
Biomarkers of Exposure 
 A metabolic study in rats showed that radio-labeled fenbuconazole is rapidly 
absorbed, distributed, and excreted following oral administration in rats. Biliary 
excretion data indicated that systemic absorption of fenbuconazole was high for all 
dosing groups. The feces were the major route of excretion. Tissue distribution and 
bioaccumulation of fenbuconazole appeared to be minimal (8, 9). 
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Mechanism of Toxicity 
 Sterol 14α-demethylase is a member of the super family of heme-containing 
cytochrome P450 enzymes involved in metabolism of endogenous and xenobiotic 
substances. The antifungal effect of azoles is due to its inhibition of sterol 14α-
demethylase in fungi and yeast, thereby blocking the biosynthesis of Ergosterol. Sterol 
14α-demethylase is not only expressed in fungi and yeast but is found in many other 
species ranging from bacteria to mammals.  Another important P450 enzyme involved in 
steroidogenesis is aromatase. Like sterol 14α-demethylase, aromatase catalyzes the 
oxidative demethylation of sterols. In contrast to sterol 14α-demethylase, which has 
several substrates in different phyla, aromatase demethylates C10 and specifically 
converts androstenedione and testosterone, resulting in estrone and estradiol, 
respectively.  In mammals, aromatase is mainly expressed in the brain and gonads, but is 
also found in placental, adipose, and bone tissue. The physiological balance between 
different sex steroid hormones is crucial for development, maintenance, and function of 
the reproductive system as well as for differentiation of the sexual phenotype during 
ontogeny. Estrogens (estrone, estriol and estradiol) are products of the androgens 
(androstenedione and testosterone), and the reaction is catalyzed by aromatase (Fig. 3). 
In mammals, differentiation of the male phenotype depends not only on testosterone but 
also on estradiol generated from testosterone by neuronal aromatase in central nervous 
system. Therefore, disturbances in aromatase expression and/or changes in its catalytic 
activity are expected to exhibit negative effects on reproduction parameters. Aromatase 
can be inhibited competitively and reversibly by azole compounds, as seen with sterol 
14α-demethylase (7).  
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FIG. 3. Biosynthesis of phytosterols, ergosterol, and mammalian sex steroid hormones. Arrows 
indicate one or more enzymatic steps. Reactions catalyzed by sterol 14α-demethylase (1) and 
aromatase (2) are indicated (7). 
 
Animal Studies 
 Oral toxicity, rat: LD50 > 2000 mg/kg body weight. Dermal toxicity, rat: LD50 > 
5000 mg/kg body weight. Inhalation toxicity, rat: LC50 > 2.1 mg/l of inhaled air. 13-
week study of hepatotoxicity in mice; 60 ppm, equal to 14 mg/kg body weight per day. 
Developmental toxicity studies, rat: 30 mg/kg body weight per day. Two-generation 
study of reproductive toxicity, rat: 5.8 mg/kg body weight per day (8, 9). 
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DIAZINON 
Uses 
 Most widely used insecticide, to control foliage and soil insects and pests of many 
fruit, nut, vegetable, forage and field crops. Approximately 13 million pounds of the 
active ingredient diazinon are used annually on agricultural areas (11). Diazinon is also 
used in sheep dips and cattle ear tags (12) and lawns and gardens to control insects, 
grubs, and nematodes in turf. It is used indoors for fly control through crack and crevice 
treatments and for veterinary use to control fleas and ticks through pet collars (11). 
 
Occurrence in the Environment 
 California, Texas & Florida are the states with the most significant usage. Diazinon 
is detected frequently in the Sacramento River and its tributaries during the dormant 
spray season. This coincides with the winter months when the area receives a majority of 
its annual rainfall. Pesticides applied during this period thus have An increased potential 
to wash off targeted areas of application and migrate with storm runoff water to streams 
in the Sacramento River Basin and creating contaminant loads. (13) 
 
Chemical and Physical Properties 
 The IUPAC name is O,O-diethylO-2-isopropyl-6-methylpyrimidin-4-pyrimidinyl 
phosphorothioate (10). The chemical formula is written as C12H21N2O3PS. The structure 
is shown in figure 4.  
 
                  
 
 
 
  
 
FIG. 4. Structure of insecticide Diazinon (10).
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 Diazinon is from the class of pesticides called Organophosphates (OPs).All 
organophosphates are derived from one of the phosphorus acids, and as a class are 
generally the most toxic of all pesticides to vertebrates. Because of the similarity of OP 
chemical structures to the "nerve gases", their modes of action are also similar.  All OPs 
are esters of phosphorus having varying combinations of oxygen, carbon, sulfur and 
nitrogen attached, resulting in six different subclasses: phosphates, phosphonates, 
phosphorothioates, phosphorodithioates, phosphorothiolates and phosphoramidates. 
These subclasses are easily identified by their chemical names. The OPs are generally 
divided into three groups--aliphatic, phenyl, and heterocyclic derivatives. Diazinon is a 
heterocyclic organophosphate (Fig. 4), and is registered as dust, granules, wettable 
powders, seed dressings, emulsifiable solutions, impregnated materials, concentrates and 
ready-to-use solutions. 
 
Acute Exposure Effects 
 Diazinon inhibits acetylcholine esterase causing nausea, dizziness, and confusion, 
with exposure to high levels causing respiratory paralysis & death (11). Acute exposure 
causes gastric outlet obstruction (14). Diazinon is an immunotoxic chemical causing 
inhibition of serine hydrolases and esterases (12). Also know to be genotoxic in human 
nasal mucosal cells (15). Inhibition of protein synthesis in HL-60 cells is seen after 
exposure to diazinon (16). 
 
Chronic Exposure Effects 
 Diazinon induces delayed neuropathy, inhibits neurite growth in mouse neuropathy, 
and reduces the levels of brain neurotransmitters GABA, taurine, glutamate, and 
aspartate (17, 18). It significantly inhibits plasma cholinesterase. Diazinon inhibits 
protein synthesis and causes Protein deficiency, which is known to depress the immune 
system.  
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 It is also known to cause lesions in the immune organs such as thymus and spleen, 
and represses lymphocyte activation by affecting the amino acid metabolism pathway 
(12). Diazinon increases the risk of Non-Hodgkin’s lymphoma in human males (19). 
 
Biomarkers of Exposure 
 Monitor the levels of acetylcholine esterase in plasma, RBC and Brain (18). Measure 
levels of diazinon metabolites such as dialkyl phosphates in urine (20). CYP1A2 and 
2B6 are also biomarkers of diazinon toxicity since bioactivation of diazinon is CYP 
specific (21). Assessment of semen quality as exposure to diazinon was associated with 
decreased semen quality in some Missouri subjects. (22) 
 
Mechanism of Toxicity 
 Diazinon causes toxicity by inhibiting the enzyme acetylcholine esterase (ace) 
thereby causing accumulation of acetylcholine at the cholinergic synapse. Diazinon by 
itself is a weak ace inhibitor however it can be activated by P450-mediated reactions to 
oxons, which are potent inhibitors of the enzyme. In human liver, CYP2C19 is the main 
enzyme involved in activation of diazinon.  During this process, the thiono-sulfur atom 
of diazinon can cause inactivation of P450. Detoxification occurs through hydrolysis of 
the oxon by calcium-dependent arylesterases or by binding of the oxon to, or hydrolysis 
of the oxon by, carboxylesterases (Fig. 5). Insects are deficient in these esterases and 
therefore the most susceptible to diazinon and other phosphothioates. (23) 
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Animal Studies 
 Acute oral toxicity in rats: LD50 = 1250 mg/kg for combined sexes causing tremors, 
hunched appearance, gasping and salivation. Acute inhalation in rats: LC50 => 
2.33mg/L, symptoms include piloerection, polyuria. Chronic toxicity in rats: for 
inhibition of plasma cholinesterase NOEL is 0.005 mg/kg/day, LOEL is 0.06mg/kg/day. 
Reproductive toxicity in rats: LOEL of 100 ppm & NOEL of 10 ppm was observed, at 
500 ppm there was decreased mating, decreased fertility indices, and increased gestation 
length. Diazinon is a  positive dermal sensitizer in humans (24). 
 
 
 
FIG. 5. Activation of Diazinon in human liver (23). 
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MATERIALS AND METHODS 
TISSUE CULTURE 
  The human breast cancer cell line, MCF-7, obtained from ATCC (Manassas, 
VA),was grown in minimal essential medium (MEM, Sigma, Saint Louis, MO) 
containing phenol red, supplemented with 10% fetal bovine serum (FBS, Atlanta 
Biologicals), 5% insulin, 5% sodium pyruvate, L-glutamine(Sigma, Saint Louis, MO). 
Cells were then switched to MEM without phenol red and with FBS for 18hrs, because 
phenol red acts as a weak estrogen (25). This was followed by treatment with 17β-
estradiol, also from Sigma, for another 18hrs or with Enable or Diazinon at various 
concentrations in the presence or absence of 17β-estradiol. Treatment with Enable and 
Diazinon; Cells were treated 0.033-3.3ng/ml of Enable and 0.3-67ppm of Diazinon with 
or without 17β-estradiol. 
 
TOTAL RNA EXTRACTION AND QUANTIFICATION 
  Cells were harvested at the end of 36 hours using Ambion lysis solution. RNA was 
extracted using the totally RNA kit of Ambion (Austin, TX). The extracted RNA was 
quantified by spectrophotometry and evaluated on an agarose gel along with a MCF-7 
standard induced mRNA, also from Ambion, to check for RNA quality. 
 
CDNA MICROARRAY 
  mRNA was prepared from the total RNA using the oligotex kit of Qiagen 
(Valencia,CA) and labeled with Cy-3 or Cy-5 using the micromax ASAP kit (Perkin 
Elmer, Boston, MA). This was followed by hybridization of the control mRNA labeled 
with Cy-5 and the test mRNA labeled with Cy-3 for 16 hrs on Phase 1 microarray slides 
containing 600 human genes (Santa Fe, NM).  
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SCANNING AND DATA ANALYSIS 
 Fluorescent signals on the slides were scanned using a Gene Pix Axon 4000b scanner 
(Union City, CA) and their intensities were analyzed using the software Acuity (Axon 
Instruments, Union City, CA). 
 
REVERSE TRANSCRIPTION 
 After visualizing 2µg of each RNA sample on a non-denaturing gel, 1µg of good 
quality total RNA was used for reverse transcription. Briefly, for a 25µl RT reaction, 
random hexamers (16µM final, Roche, Indianapolis, IN), Oligo dT (500 ng/µl, Promega, 
Madison, WI), RNA 1.0 µg, and RNAse-free water was combined and heated at 65ºC, 5 
min and allowed to cool down to room temperature. A cocktail of the following 
components was added to each sample: 5X 1st strand buffer, 0.1 M DTT (both included 
with SuperScript II), RNase block (Brinkman, Westbury, NY), 10 mM dNTPs 
(Promega, Madison, WI) and SuperScript II RT (Invitrogen, Carlsbad, CA). Cocktail 
will also be made without RT as a control. Each tube was mixed and centrifuged briefly. 
The RT reaction continued at 37ºC for 1hour. The reverse transcriptase was inactivated 
by heating at 90ºC for 5 minutes and samples cooled on ice. A reaction with and without 
reverse transcriptase was performed with each sample. 
 
REAL TIME PCR 
  A master mix containing Platinum Quantitative PCR SuperMix-UDG, ROX 
reference dye, RNAse/DNAse-free water, 10µM FAM-labeled LUX primers and 10µM 
unlabeled reverse primer was assembled. All components are from Invitrogen. The 
primers shown in Table 1, were specific for the genes selected for special consideration 
or GADPH, a house keeping gene common to most mammalian cells, and were designed 
using Invitrogen’s LUX primer designing program (available from the Invitrogen 
website) and labeled with FAM. 10µls of each sample, with and without RT, was 
combined with 40µl of the master mix in an optically clear semi-skirted PCR plate and 
reactions containing the primers, specific for the genes of interest and GADPH, were 
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done for each sample. The real time PCR was done run using an Applied Biosystems 
Prism 7700 thermocycler (Foster City, CA) using a 3 step cycling program 
recommended by Invitrogen: 50ºC, 2min hold (UDG treatment), 95ºC, 2min hold, 45 
cycles of : 95ºC, 15 sec, 55ºC, 30 sec, 72ºC, 30 sec. 
 
DATA ANALYSIS 
 The data are presented as normalized expression levels:   (expression level of gene of 
interest divided by expression level of GADPH).  The expression level is determined by 
this equation: 2 raised to the (45-Ct), Ct being the cycle number at which the threshold 
was crossed for the test gene or GADPH, and 45 is the number of cycles in the program 
(26).   
 
TABLE 1. Primers used for real-time RTPCR 
 
Gene Name PubMed Id  Oligonucleotides  5’-3’ 
Phenol sulfotransferase  U26309 forward CCCACGACTCCTGAAGACACAC 
  reverse CAACGTGCCACATCCTTTGCGFAMTG 
Intercellular adhesion 
molecule-1 J03132 forward TCTATAACCGCCAGCGGAAGA 
  reverse CACAAGAGGGAGGCGTGGCTTGFAMG 
Calreticulin  M84739 forward CGATGAGGCATACGCTGAGG 
  reverse GACAAACCTCTGCTCCTCGTCCTGTTTGFAMC 
Transforming Growth 
Factor Beta-3 XM007417 forward GGGCAAATGGCTGAGATGG 
  reverse CACGGCCCACACTTTCTTTACCACCGFAMG 
Excision Repair Protein L20046 forward GACACGTTCTGAAGTCATTGGCCCTGFAMC 
  reverse TGGTCTGCTGTTCTTGGATGGT 
Ribonucleotide 
Reductase M1 subunit X59543 forward GACATACACCCTGGCCCTGAATATGTAGFAMC 
  reverse GGGCGATGGCGTTTATTTG 
GADPH X01677 forward CATCAAGAAGGTGGTGAAGCA 
  reverse CTACACTACCACCTGGTGCTCAGTGFAMAG 
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RESULTS 
 MCF-7 Cells were grown in medium containing 10% normal FBS (NFBS), or in 
medium with 10% charcoal – dextran treated FBS, for 18h. NFBS has some inherent 
estrogen which was removed by treating with charcoal-dextran. At the end of 18h, the 
cells were treated with Enable (0.033-3.3 ng/ml) or Diazinon (0.3-300 ppm), with or 
without 17β- estradiol (see Table 2). Cells were harvested after 36h, RNA was isolated 
(Fig. 6) and microarray slides were labeled.  It was observed that cells treated with 
Diazinon above 90 ppm in the medium died. 
 
TABLE 2. Acronyms used for treatments 
Acronym Type of treatment 
NFBS MCF-7 Cells grown in medium containing normal fetal bovine serum (10%) for 36 h 
SFBS MCF-7 cells grown in medium containing charcoal-dextran treated FBS medium (10%) for 36 hrs 
NFBS T1-E2 MCF-7 cells grown in NFBS for 18h, followed by addition of 3.3 ng/ml of Enable to the medium for 18 h 
NFBS T1+E2 MCF-7 cells grown in NFBS for 18h, followed by addition of 3.3 ng/ml of Enable and 17 β-estradiol to the medium, for 18 h. 
NFBS E2 MCF-7 cells grown in NFBS for 18h, followed by addition of  17 β-estradiol to the medium, for 18 h. 
SFBS T1 MCF-7 cells grown in SFBS for 18h, followed by addition of 3.3 ng/ml of Enable  to the medium, for 18 h. 
SFBS E2 MCF-7 cells grown in SFBS for 18h, followed by addition of  17 β-estradiol to the medium, for 18 h. 
NFBS D3 MCF-7 cells grown in NFBS for 18h, followed by addition of 3 ppm  of Diazinon to the medium, for 18 h. 
NFBS D30 MCF-7 cells grown in NFBS for 18h, followed by addition of 30 ppm  of Diazinon to the medium, for 18 h. 
NFBS D50 MCF-7 cells grown in NFBS for 18h, followed by addition of 50 ppm of Diazinon to the medium, for 18 h. 
NFBS D67 MCF-7 cells grown in NFBS for 18h, followed by addition of 67ppm of Diazinon to the medium, for 18 h. 
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TREATMENT WITH ENABLE 
 
 
 
 
TABLE 3. Microarray experiments with Enable treated MCF-7 cells 
 
 
Identification of Genes Affected by Enable 
 The series of microarray experiments carried out with enable are summarized in 
Table 3. In the cells treated with 3.3ng/ml (T1), there was down-regulation of 8 genes 
and up-regulation of 34 genes as seen in Table 4 compared to untreated cells (Fig.7). 
From the down-regulated genes, PST and ICAM-1 were chosen for RT-PCR 
verification. Likewise, calreticulin and TGF β3 were selected from amongst the up-
regulated genes.  
Control (CY5) Test (CY3) Results 
SFBS NFBS No significant change in gene expression 
NFBS NFBS T1-E2 8 genes down-regulated and 34 genes up-regulated 
SFBS SFBS T1+E2 No significant change in gene expression 
SFBS SFBS T1 No significant change in gene expression 
FIG. 6.  Agarose gel electrophoresis of Enable treated MCF-7 RNA samples. 
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RT-PCR Data and Expression Levels of the Genes 
       The cDNAs were obtained after reverse transcription from the RNA samples. This 
was done was for all RNA samples mentioned in Table 3. SFBS, SFBS T1, and SFBS 
E2 were controls. A reaction without reverse transcriptase (RT) was also carried out with 
the above RNA samples. Primers (Table 1) for the respective genes were applied to all 
samples with or without RT as per Materials and Methods. The data showed that the 
genes selected for further study were up or down-regulated in the treated sample (NFBS 
T1-E2) compared to the untreated (NFBS), as predicted by the arrays. The genes which 
were down-regulated (PST and ICAM-1) were amplified one or more cycles later in the 
treated samples than the untreated samples, which showed that the treated samples had 
more copies of the mRNA for that gene and, thus, that the chemical treatment reduced 
transcription of that gene. Similarly, the up-regulated genes (calreticulin and TGF β3) 
were amplified one or more cycles before in the treated sample. Data shown in Figure 8 
indicate the cycle numbers at which the threshold was crossed by the genes. The gene 
expression levels and the normalized expression levels against the standard gene 
GADPH were calculated from these data (Fig. 9). 
FIG. 7. Microarray image of NFBS (control) vs. NFBS T1-E2 (test). 
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TABLE 4. Gene expression profile after treatment with Enable (T1) 
 
Ratios above 1.5 are considered to up-regulated and below 0.6 down-regulated. Values are fold change 
 at each time point relative to control. Those in bold have been verified by real-time PCR. 
Pub Med ID Gene Name Ratio 
J03132 Intercellular adhesion molecule-1 0.2845 
K00558 Alpha-tubulin 1.8 
L05094 Ribosomal protein L27 1.868 
L10752 3-methyladenine DNA glycosylase 2.634 
M11717 Heat shock protein 70 2.0465 
M34664 Heat shock protein 60 (chaperonin) 2.7425 
M59907  Melanoma-associated antigen ME491 2.702 
M62505 C5a anaphylatoxin receptor 0.2155 
M84739 Calreticulin 2.665 
M93133 Cholesterol 7-alpha-hydroxylase (P450 VII) 0.1795 
NM000274  Ornithine aminotransferase 2.1885 
NM000931  Tissue plasminogen activator 2.733 
NM001006 Ribosomal protein S3A (RPS3A). 1.812 
NM001011 Ribosomal protein S7 (RPS7). 1.923 
NM001022 Ribosomal protein S19 (RPS19). 1.823 
NM002426  Macrophage metalloelastase 2.0755 
NM002737 Protein kinase C alpha 1.8965 
NM003104 Sorbitol dehydrogenase 2.5835 
NM007310  Catechol-O-methyltransferase 2.143 
NM030938 Hypothetical protein DKFZp566I133 2.784 
U26309 Phenol sulfotransferase 0.2955 
U61981 DNA mismatch repair/binding protein (MSH3) 0.319 
X00351 Beta-actin 2.043 
X01677 Glyceraldehyde 3-phosphate dehydrogenase 1.964 
X16869 Elongation factor-1 alpha 2.273 
XM002028 Cathepsin S 0.45 
XM002247 Alpha-prothymosin 2.344 
XM004689  Insulin-like growth factor binding protein 3 2.747 
XM004968 Hepatocyte growth factor receptor 2.498 
XM005893  Mitochondrial voltage dependent anion channel (VDAC2) 2.652 
XM007417 Transforming growth factor-beta3 1.597 
XM007615 Ribosomal protein S17 2 
XM007704 Fumarylacetoacetate hydrolase (FAH) 2.6735 
XM007981 Type I transmembrane protein Fn14 (FN14) 2.33 
XM008176 MYB binding protein 2.305 
XM008437  Nerve growth factor receptor 2.5825 
XM008817  Membrane bound cytochrome b5 2.6465 
XM009082  Low density lipoprotein receptor 2.541 
XM011855 Ribosomal protein L13A 2.161 
XM012041 KAI1 metastasis suppressor gene (CD82) 0.405 
XM012549 Ribosomal protein L13 1.906 
XM046740 Similar to rat tricarboxylate carrier-like protein  0.222 
NM004106 High affinity IgE receptor gamma chain (FcERIgamma) 2.812 
X13403 Octamer binding protein 1 2.274 
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FIG. 8. RT PCR amplification cycles for Enable treatment. GADPH is the standard gene. A, 
the cycle at which PST crosses the threshold in all samples. B, C and D show the cycles at 
which ICAM-1, calreticulin and TGF β3 cross the threshold in different samples, respectively.
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FIG. 9. Normalized gene expression levels for Enable treatment. A, B, C and D 
represent individuals expression levels of PST, ICAM-1, Calreticulin and TGF β3 
mRNA as compared with GADPH, respectively. 
 22
TREATMENT WITH DIAZINON 
 
 
TABLE 5. Microarray experiments with Diazinon treated MCF-7 cells 
 
Identification of Genes Affected by Diazinon 
 The microarray experiments carried out to examine the effects of Diazinon on gene 
expression of MCF-7 cells are summarized in Table 5, using the isolated RNA (see Fig. 
10).  For PCR verification, four genes were chosen from 67ppm treatment levels (Fig 
11). From these, excision repair protein (ERCC-5) and ribonucleotide reductase subunit 
M1 (RNRM1) were significantly down regulated, transforming growth factor beta 3 
(TGF β3) was significantly up-regulated (Table 6). Calreticulin did not seem to be up-
regulated as compared to untreated cells. However, it was selected since it was 
significantly up-regulated in the 30 & 50 ppm levels.  
Control (CY5) Test (CY3) Results 
NFBS NFBS D3 No Significant Difference in gene expression 
NFBS NFBS D30 16 genes up-regulated  
NFBS  NFBS D50 24 genes up-regulated 
NFBS  NFBS D67 3 genes down-regulated and 28 genes up-regulated 
FIG. 10. Agarose gel electrophoresis of Diazinon treated MCF-7 RNA samples. 
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RTPCR Data & Expression Levels 
 Reverse Transcription and RT PCR were carried out, just as for the Enable- treated 
RNA samples. The data obtained confirmed the results of the microarray analysis. Also 
the calreticulin gene was significantly up-regulated in treated samples (67ppm), because 
it crossed the threshold much earlier as compared to the untreated sample (Fig. 12). 
Normalized expression levels were computed for all the four genes can be seen in Fig 
13.   
FIG. 11. Microarray image of NFBS (control) vs. NFBS D67 (test). 
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TABLE 6. Gene expression profile after treatment with Diazinon (D 67) . 
Pub Med ID Gene Name Ratio 
L20046 ERCC 5 (excision repair protein) 0.524 
X59543 Ribonucleotide reductase M1 subunit 0.55 
U50079 Histone deacetylase 1 0.704 
X15759 Cytochrome c oxidase subunit II 0.823 
M11717 Heat shock protein 70 0.953 
M34664 Heat shock protein 60 (chaperonin) 0.984 
XM011855 Ribosomal protein L13A 1.073 
X13403 Octamer binding protein 1 1.119 
XM012041 KAI1 metastasis suppressor gene (CD82) 1.131 
XM007615 Ribosomal protein S17 1.142 
X15187 Glucose-regulated protein 94 1.219 
XM012549 Ribosomal protein L13 1.361 
X16869 Elongation factor-1 alpha 1.379 
NM002737 Protein kinase C alpha 1.397 
M84739 Calreticulin 1.47 
X66403 Acetylcholine receptor epsilon 1.745 
XM014287 pM5 protein 1.759 
NM000274  Ornithine aminotransferase 1.782 
XM008176 MYB binding protein 1.796 
XM007981 Type I transmembrane protein Fn14 (FN14) 1.802 
L10752 3-methyladenine DNA glycosylase 1.805 
XM007417 Transforming growth factor-beta3 1.814 
NM004106 High affinity IgE receptor gamma chain (FcERIgamma) 1.85 
XM005893  Mitochondrial voltage dependent anion channel (VDAC2) 1.864 
NM003104 Sorbitol dehydrogenase 1.905 
NM000931  Tissue plasminogen activator 1.934 
Y10313 Interferon related developmental regulator IFRD1  (PC4) 1.934 
NM002426  Macrophage metalloelastase 1.94 
XM004968 Hepatocyte growth factor receptor 1.954 
XM008437  Nerve growth factor receptor 1.965 
NM000853 Glutathione S-transferase theta-1 1.966 
AF096290 Very long-chain acyl-CoA synthetase 1.974 
XM007704 Fumarylacetoacetate hydrolase (FAH) 1.983 
XM004689  Insulin-like growth factor binding protein 3 1.986 
NM030938 Hypothetical protein DKFZp566I133 1.988 
XM008817  Membrane bound cytochrome b5 2.011 
NM001888 Crystallin 2.021 
M59907  Melanoma-associated antigen ME491 2.049 
XM004212 Diubiquitin (UBD) 2.053 
XM009082  Low density lipoprotein receptor 2.114 
M23452 Macrophage inflammatory protein-1 alpha 2.12 
Ratios above 1.5 are considered to up-regulated and below 0.7 down-regulated. Values are fold change 
 at each time point relative to control. Those in bold have been verified by real-time PCR. 
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FIG. 12. RT PCR amplification cycles for Diazinon treatment. GADPH is the standard gene. 
A, the cycle at which ERCC-5 crosses the threshold in all samples. B, C and D are the cycles 
at which RNRM1, calreticulin and TGF β3 cross the thresholds in different samples, 
respectively. 
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 FIG. 13. Normalized gene expression levels for Diazinon treatment. A, B, C and D 
represent individuals expression levels of ERCC-5, RNRM1, Calreticulin and TGF β3 
mRNA as compared with GADPH, respectively.
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DISCUSSION 
PHENOL SULFOTRANSFERASE 
 
 
 
 
 
 
 
 
  
 Sulfonation is an important metabolic pathway involved in the detoxification and or 
activation of a range of endogenous compounds (e.g., monoamine neurotransmitters, 
thyroid and steroid hormones), drugs (e.g., minoxidil) and xenobiotics, (e.g., aromatic 
amines and benzylic alcohols of polycyclic aromatic hydrocarbons). This reaction 
involves transfer of a sulfonate group from the 3'-phosphoadenosine-5'-phosphosulfate 
(PAPS) to the acceptor substrate (Fig. 14). In the case of xenobiotics, this reaction is 
catalyzed by a group of cytosolic sulfotransferase enzymes (STs). However, it is 
important to recognize that a number of membrane bound STs also exist. Based on 
amino acid alignments, the cytosolic sulfotransferases have been divided into three 
families: phenol, hydroxysteroid and flavonol STs (28).  
 In the human, there are three members of the phenol sulfotransferase family 
(SULT1A1, SULT1A2, and SULT1A3). DNA sequences and the structures of these 
three enzymes are highly homologous, and all three genes are tightly linked on 
chromosome 16p12.1-p11.2. All of the human aryl STs share greater than 90% sequence 
homology at the amino acid level but vary markedly in their substrate preferences (28, 
29). Several human tissues contain two major P-ST forms that differ in their substrate 
specificity, sensitivity to inhibitors and physical properties despite their sequence 
homology (92% in amino acid sequences).  
FIG. 14. Phenol sulfotransferase (27). 
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One is relatively thermostable (TS-PST, SULT1A1 and SUL1A2) and the other is 
thermo labile (TL-PST, SULT1A3). TS-PST preferentially catalyzes the sulfation of 
millimolar concentrations of simple phenols, whereas TL-PST catalyzes the sulfation of 
millimolar concentrations of dopamine. The P-ST family consists of four subfamilies, 
phenol sulfotransferases (SULT1A), dopa/tyrosine (or thyroid hormone) 
sulfotransferases (SULT1B), hydroxylamine sulfotransferases (SULT1C), and estrogen 
sulfotransferases (SULT1E) (30). Sulfonation, along with detoxification can also lead to 
biological activation of compounds rendering them carcinogenic. Several chemicals such 
as TCDD are known to inhibit and therefore down-regulate phenol sulfotransferases 
(31). Many roles of sulphonation are summarized below; 
 
Detoxification of Xenobiotics and Chemical Defense 
 Sulphonation is considered an important component of what is called phase II of 
xenobiotic metabolism, i.e., the conjugation and true detoxification step, and is, a central 
feature of the body’s chemical defense. The classical view of sulphonation is that it 
protects against the toxic, or potentially toxic, effects of numerous xenobiotics and their 
metabolites, because sulfate conjugates are in general more polar, more water soluble 
and, more readily excreted in urine or bile. A number of drugs and other xenobiotics are 
directly conjugated with sulfate, including compounds acting at the b-adrenergic 
receptor, paracetamol and dietary catechols (32).  
 
Sulphonation Leads to Biological Activation 
 There are a number of important examples showing that sulfate conjugates are more 
biologically active than the corresponding free compounds. However, probably the most 
interesting example of bioactivation via sulphonation is in the case of dietary and 
environmental mutagens and carcinogens, for which a large number of chemicals 
sulphonation is the terminal step in the essential metabolic activation pathway to the 
ultimate DNA- or protein-adducting species. Examples of chemicals for which 
sulphonation plays a crucial role in their bioactivation include aromatic amines 
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(including heterocyclic amines presented in cooked meat and fish) and benzylic alcohols 
of chemicals such as polycyclic aromatic hydrocarbons, safrole and estragole. There now 
exists ample in vivo and in vitro evidence for the involvement of sulphonation in this 
process. Mice which are pre-treated with an inhibitor of sulfotransferase such as 
pentachlorophenol prior to treatment with safrole are much less susceptible to 
tumorigenesis than untreated mice (32). 
 
Dietary Compound Interaction with Sulphonation 
 Most SULTs are expressed (to varying degrees) in the human gastrointestinal 
tract. In light of this fact and of the important role sulphonation plays in the bioactivation 
of dietary procarcinogens, it is reasonable to assume that there is potential for the 
production of highly reactive, unstable, mutagenic sulfuric acid esters within the 
gastrointestinal tract. This may be an important mechanism in, colon cancer in which 
dietary aromatic amines known to be activated via sulphonation are implicated and we 
have, therefore, been curious as to whether other dietary chemicals may act as inhibitors 
of SULTs activating such procarcinogens (32). Individuals suffering from dietary 
migraine are deficient in P-PST as compared to the other enzymes responsible for 
metabolizing dietary migraine-inducing compounds like tyramine in the diet (33). 
 
Disorders Associated with Sulfotransferases 
 To date, no disease associated with a defect in any cytosolic sulfotransferase is 
known. However, there is extreme variation in the expression of various SULTs within 
the human population and there is good evidence for the existence for a genetic 
polymorphism affecting the P-PST isoform (32). Recent studies have shown that breast 
cancer cells have very low estrogen sulfotransferase activity, and their estrogen-sulfating 
activity is attributable to phenol-preferring sulfotransferases (SULT1A). Interestingly, 
there is evidence that SULT1A1 genotype influences the age of onset of the disease in 
patients. SULT1A mRNA Levels were seen to be induced after tamoxifen treatment 
(34).   
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INTERCELLULAR ADHESION MOLECULE-1 
 Intercellular adhesion molecule (ICAM)-1 (CD54) is a member of the 
immunoglobulin gene super family and is expressed on endothelial cells, epithelial cells, 
and fibroblasts, as well as T-cells, B-cells, dendritic cells, macrophages, and eosinophils. 
It consists of a 76-114 kDa chain glycoprotein, with a core polypeptide of  
approximately 55 kDa, and is composed of one short cytoplasmic, one 
transmembranous, and five immunoglobulin (Ig)-like extracellular domains. The ligands 
for ICAM-1 are the b2 integrins, leucocyte function associated molecule (LFA)-1 
(CD11a/CD18) and macrophage antigen (Mac)-1 (CR3, CD11b/CD18) and the 
rhinovirus (RV). Binding of ICAM-1 to ligand adhesion molecules has profound effects 
on cell adhesion and activation (35, 36, 37). 
 
Expression of ICAM-1 on T Cells During Activation 
 The migration of T-cells from blood into the lungs constitutes an important 
component of the inflammatory response in the airways. During this process a series of 
different surface adhesion molecules are up-regulated and down-regulated, dictating 
their ability to migrate into lymph nodes and subsequently into inflamed tissue sites. 
Naive T-cells migrate from blood into the tissue-associated lymph nodes through 
postcapillary high endothelial venules to be "instructed" by antigen presenting cells 
(APCs), (Fig.15). Upon antigenic stimulation, T-cells shed L-selectin and acquire other 
adhesion molecules such that, e.g., activated cytotoxic T-cells express high levels of 
ICAM-1 well as LFA-1.  ICAM-1 is weakly expressed on resting T-cells, in contrast to 
ICAM-3 which is expressed at higher levels. Adhesion of resting T-cells to LFA-1 
occurs primarily via ICAM-3 followed by ICAM-1, which establishes more stable cell-
cell interactions. ICAM-1 is the major ligand for LFA-1 on activated T-lymphocytes. 
Up-regulation of ICAM-1 on T-cells can also be observed following exposure to both 
live and inactivated viruses (35, 37).  
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Cytokine Production 
 Emerging evidence suggests that binding of ICAM-1 on T-cells can have an 
important effect on cytokine production. Co-engagement of CD3 with ICAM-1 enhances 
the activation of murine CD4+ and CD8+ T-cells in an accessory cell-free culture system 
and induces production of IL-3 and IFN-γ, which is four times greater in CD8+ T-cells 
compared to CD4+ T-cells. Anti-ICAM-1 mAb inhibits in vitro production of TNF-α, 
IFN-γ and IL-1 by phytohaemagglutinin (PHA)-activated human T-cells (35). 
 
Helper Activity for B Cells 
 Interaction between LFA-1 expressed on B-cells and ICAM-1 on activated T-cells is 
important in early events of T-cell-dependent B-cell activation, proliferation and 
differentiation (35). 
FIG.15. T-cell activation interaction between ICAM-1 and LFA-1 (37). 
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Soluble ICAM-1 
 A circulating, soluble form of ICAM-1 (sICAM-1) has been detected in culture 
supernatants and human body fluids and is thought to be derived through shedding of 
surface ICAM-1. The mechanism of ICAM-1 shedding from the cellular membrane is 
poorly understood. It is possible that activation of the cells induces the expression or 
activity of a cell membrane protease which is able to cleave membrane-bound ICAM-1. 
In culture the levels of sICAM-1 correlate with the degree of immune cell activation and 
seem to be an early and sensitive marker for activation of both T-cells and Bcells. 
Several studies suggest that sICAM-1 may participate in a feedback down-regulatory 
mechanism. In vitro, recombinant sICAM-1 are able to inhibit homotypic T-cell 
aggregation, cytolytic interaction between cytotoxic cells and target cells, major 
histocompatibility complex (MHC)-restricted cytotoxicity, antigen-induced proliferation 
and antigen-triggered induction of cytokines in T-cells (35). 
 
ICAM-1 in Allergic Inflammation and Asthma 
 Evidence accumulated to date has shown a prominent role for ICAM-1 in allergic 
inflammation. Asthma is a chronic inflammatory disease characterized by accumulation 
of activated eosinophils and T-lymphocytes in the bronchial mucosa. Lung cell 
infiltration in asthma is regulated by several pathophysiological mechanisms, including 
increased expression of cell adhesion molecules and levels of chemoattractants. Several 
studies have shown prominent up-regulation of ICAM-1 in asthmatic airways. Increased 
ICAM-1 expression in asthma has been reported on eosinophils, T-cells, and bronchial 
endothelial and epithelial cells (35). 
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Breast Cancer 
 ICAM-1 expression is seen in almost 50% of breast cancer patients. ICAM-1 
expression has negative correlation with tumor size. Patients with ICAM-1 positive 
tumors have better relapse-free and overall survival as compared to the negative tumors. 
This suggests that expression of ICAM-1 on cancer cells may have a role in tumor 
suppression (37, 38). 
 
Atherosclerosis 
  One of the earliest events in atherosclerosis is interaction of circulating mononuclear 
leukocytes and the endothelium. Endothelial cell (EC) activation by cytokines results in 
expression of adhesion molecules and production of chemotactic factors, augmenting 
leukocyte adhesion and recruitment, respectively. The incidence of atherosclerosis in 
premenopausal women is significantly less than that observed in age-matched males 
with similar risk profiles. Because estrogen has gene regulatory effects, we investigated 
whether 17β-estradiol (E2) can inhibit cytokine-mediated EC adhesion molecule 
transcriptional activation. Cultured human umbilical vein EC (estrogen receptor–
positive) were propagated in gonadal hormone–free medium and were E2-pretreated for 
48 h before IL-1 activation. Assessed by FACS analysis, E2  strongly (60–80%) 
inhibited IL-1–mediated membrane E-selectin and vascular cell adhesion molecule-1 
induction, and intercellular adhesion molecule-1 hyper induction. 17α-estradiol (an 
inactive E2 stereoisomer) had no effect. This inhibition correlated with similar 
reductions in steady state–induced E-selectin mRNA levels, and was abrogated by the 
E2 antagonist ICI 164,384, demonstrating a specific, estrogen receptor–mediated effect. 
Nuclear runoffs confirmed suppression at the transcriptional level (39).  
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CALRETICULIN 
 Ca2+ is a universal signaling molecule that affects diverse cellular functions such as 
secretion, contraction–relaxation, cell motility, cytoplasmic and mitochondrial  
metabolism, synthesis, modification, and folding of proteins, gene expression, cell cycle 
progression, and apoptosis. The endoplasmic reticulum (ER) plays a central role in 
maintaining intracellular Ca2+ levels. Ca2+ is released from the ER via the InsP3 receptor 
and is taken back up into the ER via a Ca2+ pump known as SERCA. Ca2+ also enters the 
cytoplasm via channels in the plasma membrane (40).  
 Calreticulin is an ER chaperone and has a role, via the calreticulin/calnexin cycle, in 
the proper folding of many proteins and glycoproteins. It is also a major Ca2+binding/ 
buffering protein in the lumen of the ER  and, as such, is involved in several of the 
processes that comprise cellular Ca2+ homeostasis, including Ca2+ storage in the ER, 
Ca2+ release from the ER. Calreticulin has several distinct structural domains. The N-
terminal domain and central, P-domain of calreticulin are responsible for its chaperone 
(protein folding) activity, whereas the C-terminal, acidic region plays a key role in Ca2+ 
storage within the ER and in ER retrieval of the protein, (Fig. 16) (40). 
 
Calreticulin an Upstream Regulator of Calcineurin 
 Calreticulin is highly expressed in embryonic heart where it presumably plays an 
important role during cardiac growth and differentiation. Calcineurin is a highly 
conserved, Ca2+/calmodulindependent serine/threonine phosphatase (phosphatase 2B). 
The activation of calcineurin occurs in response to sustained Ca2+ release from the ER 
and Ca2+ influx across the plasma membrane. The role of calcineurin is critical in cardiac 
physiology, pathology, and development. Ca2+-dependent, cardiac-specific 
transcriptional processes are impaired in the absence of calreticulin. Studies with 
calreticulin-deficient rescue mice indicate that calcineurin-dependent pathways are 
involved in the effects of calreticulin-deficiency on cardiac development, and may be 
involved in the effects on metabolism. Calreticulin appears to be a key upstream 
regulator of calcineurin function (40). 
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Role of Calreticulin in the Regulation of Osteoblastic Differentiation 
 Recent studies have shown that calreticulin can indeed be detected in the nucleus.  
The ability of calreticulin to inhibit nuclear hormone receptor activity has been directly 
demonstrated for glucocorticoid, androgen, and retinoic acid receptors. Calreticulin gene 
expression is seen during osteoblastic cell differentiation but not seen in mineralizing 
cultures of osteoblasts. Constitutive expression of calreticulin in osteoblastic cells 
inhibits mineralization. This inhibition is most likely mediated through specific 
modulation of gene expression by calreticulin, by interacting with the vitamin D receptor 
to inhibit its binding to cognate response elements in vitro, and selectively inhibit certain 
vitamin D-mediated transcriptional responses in vivo. For example osteocalcin gene is 
inhibited by endogenous expression of calreticulin but osteopontin gene isn’t (41). 
 
 
 
FIG. 16. A putative model of calreticulin (40). 
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Protein Folding 
 Studies using cells derived from crt-/- embryos indicate that protein folding in the 
ER is compromised in the absence of calreticulin resulting in the accumulation of mis-
folded protein and activation of unfolded protein responses. Ca2+ release from the ER is 
also inhibited in crt-/- cells, likely because Ca2+ handling in the ER and the 
folding/trafficking of cell surface receptors are impaired. Studies with calreticulin 
deficient cells have also revealed that protein folding and Ca2+ signaling processes in the 
ER are highly interdependent. Both calreticulin and calnexin act as lectins and molecular 
chaperones, and they bind monoglucosylated proteins and associate with the thiol 
oxidoreductase ERp57, which promotes disulfideformation/isomerization in 
glycoproteins. Folding substrates associate transiently with calnexin and calreticulin and 
enter cycles (Fig. 17) of de-glucosylation/re-glucosylation which plays an important role 
in their association with the chaperones. Protein folding is accelerated in the absence of 
calreticulin and quality control is compromised. There is an accumulation of unfolded 
proteins and a triggering of the unfolded protein response (UPR), activated in the 
absence of calreticulin. ER molecular chaperones of calreticulin/calnexin cycle have 
overlapping and complementary, but not redundant, function. The absence of one 
chaperone can have devastating effects on the function of the others, compromising 
overall quality control of the secretory pathway and activating UPR-dependent pathways 
(42, 43). 
 
Over-expression of Calreticulin 
 Calreticulin mRNA is regulated by androgen and androgen induction of calreticulin 
mRNA resists inhibition of protein synthesis (44). Also, heat shock, and heavy metals 
such as zinc and cadmium are consistently found to increase transcription of calreticulin. 
These studies suggest that (a) calreticulin is regulated at the transcriptional level, and (b) 
calreticulin, appears to function as a heat shock/stress-response gene (45). Widely 
distributed and highly conserved calreticulin has been suggested to play a role as a Ca2+ 
storage protein of intracellular Ca2+ stores.  
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In cells that over-express calreticulin, the Ca2+ content increases and 80% of the 
increased Ca2+ content is found in Ca2+ stores (46). Over-expression of Calreticulin 
increases Ca2+ fluxes across the ER but decreases mitochondrial Ca2+ and membrane 
potential. The increased Ca2+ turnover between the two organelles might damage 
mitochondria, accounting for the increased susceptibility of cells expressing high levels 
of calreticulin to apoptotic stimuli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 17. Protein folding by the calreticulin / calcinexin cycle in ER (47). 
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TRANSFORMING GROWTH FACTOR β3 
 It is now evident that TGF-βs not only promote cellular growth but are also capable 
of either promoting or inhibiting cell death, depending upon the cell-type examined. The 
numerous functions of TGF-βs include cell cycle control, regulation of early 
development, differentiation, extracellular matrix formation, hematopoesis, 
angiogenesis, chemotaxis and immune functions. TGF-βs also act contextually, because 
their actions often depends on environmental cues, i.e. the cell type, the differentiation 
state of cells, and the presence of other growth factors, best exemplified by their capacity 
to either stimulate or inhibit proliferation, TGF- β3s have the potential to regulate 
processes in part controlled by interactions between cellular receptors and components 
of the extracellular matrix, such as cell migration, homing, and location during 
development. In mice lacking TGF-β3, the palate shelves fail to fuse leading to a cleft 
palate (48).  
 
Role of TGF β3 Male Reproductive Physiology 
 TGF-β3 is known to regulate multiple physiological functions in the testis they 
include spermatogenesis, Leydig cell steroidogenesis, extracellular matrix synthesis and 
testis development. TGF-β3 also regulates Sertoli cell tight junction (TJ) dynamics in 
vitro via the mitogen-activated protein (MAP) kinase pathway, suggesting that this 
cytokine plays a crucial role in regulating the opening and closing of the blood–testis 
barrier (BTB). This in turn regulates the passage of pre-leptotene and leptotene 
spermatocytes across the BTB (49). 
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Role in Cell De-Differentiation 
 TGF β3 is reported to regulate cell proliferation during development and can also 
influence the commitment or the differentiation, or both, of neural progenitor cells to 
retinal fates. Neural stem cells when treated with TGF β3 differentiate into retinal cells 
instead of neural cells. This may be due to selective glial cell death in the cultured cells 
by TGF β3, because it induces apoptotic cell death in oligodendrocytes by activation of 
caspases (50). 
 
Retinoic Acid Down-Regulates TGF β3  
 Retinoic acid, a chemo-preventive agent for epithelial cancers, binds to retinoic acid 
receptors (RAR) as well as retinoic X receptors (RXR). Upon dimerization of the 
activated receptors, they enter the nucleus and interact with specific DNA segments 
affecting transcription. A growth factor for lung cancer is TGF- β3. In vitro studies show 
that RA inhibits TGF- β3 by inhibiting transcription, there by inhibiting the proliferation 
of lung cancer (51). 
 
Role in Hepatitis and Cirrhosis of Liver 
 Liver tissues of patients suffering from hepatitis have a high expression of     TGF-
β3. The expressing intensity being stronger incase of cirrhosis and chronic hepatitis as 
compared to acute hepatitis. As the expression of TGF-β3 increases, the level of serum 
bilirubin ascended. Hence, it may be concluded that expression of TGF-β3 is correlated 
with severe hepatitis and the progress of liver cirrhosis (52). 
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EXCISION REPAIR PROTEIN-5 
 Nuclear excision repair (NER) is one of the primary pathways by which mammalian 
cells remove DNA lesions caused by both endogenous and exogenous agents. Both 
endogenous and exogenous exposures to carcinogens or genotoxic agents cause cell 
cycle delays allowing repair of DNA damage and DNA repair capacity is central to 
maintaining normal cellular functions. A wide spectrum of structurally unrelated lesions 
such as UV-induced photoproducts, bulky chemical adducts, and certain types of DNA 
cross-links are efficiently removed by the NER pathway. In the process of repair, the 
products of more than a dozen genes are involved in damage recognition, incision, 
excision, elongation, and ligation and collectively restore the normal structure (53, 54).  
 Excision Repair protein-5 (ERCC5 / XPG) has endonuclease activities and plays a 
role in the incision of the 5' side and the 3' side of the DNA lesions, respectively (54). 
Individuals with a defect in the XPG protein suffer from xeroderma pigmentosum (XP) 
resulting from an inability to perform DNA nucleotide excision repair properly (53). In 
lung cancer patients, the levels of ERCC5 are significantly lower than in normal 
individuals (10). This is also true for patients with squamous cell carcinoma of the head 
and neck (11).  A defect in this gene may increase the susceptibility to cancer by 
allowing the unrepaired DNA damage to remain in place, thus leading to carcinogenesis. 
DNA repair capacity varies from individual to individual, and reduced expression of 
ERCC5 and other NER regions might increase the susceptibility of an individual to lung 
cancer. 
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RIBONUCLEOTIDE REDUCTASE SUBUNIT M1  
 Ribonucleotide reductase (RR), plays a key role in the synthesis of DNA and is 
responsible for the reduction of ribonucleotides to their corresponding 
deoxyribonucleotides, providing a balanced supply of precursors for DNA synthesis and 
repair. Recent studies have shown that there are three human RR subunits: hRRM1, 
hRRM2 and p53R2. hRRM1 is a large peptide chain, and hRRM2 and p53R2 are small 
protein subunits of RR. RRM1 is one of the two components of ribonucleotide reductase, 
whose cellular function is to provide the deoxynucleotides required for DNA synthesis 
and repair through catalysis of ribonucleoside diphosphates to the corresponding 
deoxyribonucleosides. Ribonucleotide reductase catalyzes the rate-limiting step in 
deoxyribonucleotide biosynthesis. The activity of this heterodimeric enzyme is 
dependent upon the expression of both its large and small subunits (55, 56). The P53 
protein directly interacts with p53R2 and hRRM2 but not hRRM1 while hRRM1 
interacts weakly with p53R2, hRRM2. After exposure to UV, p53R2 and hRRM2 
dissociated from p53 and bound hRRM1 in these cells. Before UV treatment all the three 
subunits are localized in the cytoplasm and after treatment they translocate to the nucleus 
as seen in Fig. 18 (56, 57). 
 
RRM1 and Lung Cancer 
  There is a relationship between frequent allele loss on human chromosome 11p15.5 
and its association with metastatic spread in patients with lung cancer. The RRM1 gene 
is located in this region, suppresses invasion, migration, and in vivo metastasis formation 
through up-regulation of the PTEN tumor-suppressor gene, when over-expressed in 
human and mouse lung cancer cell lines (58).  
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FIG. 18. Model for p53 regulation of ribonucleotide reductase activity for DNA repair in 
response to UV damage (57). 
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CONCLUSION 
      Some of the adverse health effects known to be caused by exposure to agricultural 
chemicals proposed in animals and humans are cleft lip/cleft palate, feminization of 
male offspring, early onset of puberty in female offspring, neural tube defects. 
  In MCF-7 cells treated with Enable, a well known fungicide, there was down-
regulation of eight genes and up-regulation of thirty four genes at 3.3 ppb, compared to 
untreated cells. Genes that were chosen for PCR verification are not only vital for 
normal immune, cellular and toxicological functions, but also are implicated in cancers, 
atherosclerosis, inflammation reactions in asthma and liver cirrhosis collectively. 
   In MCF-7 cells treated with Diazinon, an insecticide, three genes were down-
regulated and twenty seven up-regulated. The genes chosen for special consideration 
played important roles in DNA synthesis and repair, cell differentiation and normal 
immune function. Defects in these genes seem to increase susceptibility to different 
kinds of cancer. 
   These studies were designed to provide base-line data on gene expression-altering 
capacity of Enable and Diazinon. Knowledge of the altered genes can aid in 
extrapolation to altered physiological systems in vivo, on exposure to these chemicals. 
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